The first question about a weight-management prescription is usually practical: what is available in BC, what will it cost, and where do I start? The confusing part is that a medicine's ingredient, brand name, approved use and insurance coverage can point to different answers.
This guide brings those questions together. Start with the product comparison, then use the cost guide and appointment checklist to prepare for a conversation with a licensed clinician.
The quick answer: Ozempic and Wegovy contain semaglutide; Mounjaro and Zepbound contain tirzepatide. Their Canadian indications differ. A prescription, insurance approval and pharmacy availability are separate decisions. Start with a clinical assessment, then check the exact prescribed product with your pharmacist and insurer.
Which medicine is which?
| Product | Active ingredient | Main distinction for someone researching weight management |
|---|---|---|
| Ozempic | Semaglutide | A diabetes product; use for weight management is a different question from its diabetes indication. |
| Wegovy | Semaglutide | A product with a chronic-weight-management indication under its Canadian monograph. |
| Mounjaro | Tirzepatide | A diabetes product; do not assume its coverage applies to weight management. |
| Zepbound | Tirzepatide | A product with a chronic-weight-management indication under its Canadian monograph. |
These are orientation summaries, not the complete indications or eligibility criteria. The current Canadian product records and linked monographs are available for Ozempic, Wegovy, Mounjaro and Zepbound.
Semaglutide acts at the GLP-1 receptor. Tirzepatide acts at both GIP and GLP-1 receptors. That distinction explains why tirzepatide appears in GLP-1 discussions, but it does not select a treatment for an individual.
What changed in 2026?
Canadian options expanded with generic semaglutide approvals. Health Canada announced an Ozempic-referencing generic in April and a Wegovy-referencing generic, Sevmia, in June. Our generic semaglutide guide explains product status and the specific late-August recall that readers should check.
There was also an indication update for Zepbound. On June 11, 2026, Health Canada recorded an additional use for moderate-to-severe obstructive sleep apnea in adults with obesity, alongside reduced-calorie eating and increased physical activity. This applies to a defined population; it does not make tirzepatide a general treatment for snoring. See the Health Canada authorization record.
How to start in British Columbia
You can begin by asking your family doctor or nurse practitioner for a weight-management discussion. If you are considering a private or virtual service, compare the assessment, follow-up and total charges before committing.
A useful first conversation covers your goals, health history, medicines, previous approaches and the support you need over time. Bring a medication list to the clinician. Ask how the service handles follow-up, questions between appointments and an eventual change in treatment.
Use these questions when comparing services:
- Who conducts the assessment, and how can I check their licence?
- Is the consultation fee payable even if no prescription is issued?
- Are follow-up visits included, or charged separately?
- Can the prescription go to my usual licensed pharmacy?
- Who answers questions if I feel unwell or cannot obtain my medicine?
- What happens to my care if I cancel a membership?
The value of a service is easier to judge when it explains the whole care process. A low introductory assessment fee may cover only one small part of it.
What results should I expect?
Clinical trials can explain average outcomes in defined groups, but they cannot predict your result. In STEP 1, adults without diabetes assigned semaglutide alongside lifestyle intervention lost an average of 14.9% of their starting weight at 68 weeks, compared with 2.4% in the placebo group. The SURMOUNT-1 trial also found substantial average weight reduction with tirzepatide in its study population.
Those separate trials do not form a direct comparison. Participants, study methods and treatment conditions matter. Ask your clinician what a realistic outcome would be for you, which health measures will be followed, and how the plan will be adjusted if the treatment is not helping.
Long-term planning matters too. SURMOUNT-4 found weight regain after tirzepatide withdrawal in its trial population. Include affordability, ongoing support and the plan for stopping in the first conversation, rather than waiting until a prescription becomes difficult to maintain.
What about side effects and suitability?
The product monographs describe gastrointestinal side effects and important warnings, contraindications and interactions. Pregnancy plans, other medicines and some personal or family medical histories can affect suitability. A prescriber and pharmacist should review these with you for the exact product.
Before leaving the appointment, ask: which effects are expected, which require prompt help, and whom should I contact? Request written instructions for your prescription. A comparison article cannot safely supply an individual dosing or switching plan.
If you are having severe symptoms or an emergency, seek urgent medical care. For non-emergency health information in BC, call 8-1-1.
Will BC PharmaCare or private insurance pay?
There is no single coverage rule for every GLP-1 medicine. BC has a Special Authority pathway for semaglutide for diabetes. That is not blanket coverage for weight management. The province's December 18, 2025 Wegovy decision records a non-benefit outcome.
Private plans vary. Ask about the exact eight-digit Drug Identification Number, or DIN, and the reason it was prescribed. A plan that covers a diabetes drug may exclude weight-management treatment. Ask whether prior authorization, a deductible or an annual maximum applies.
Our BC GLP-1 cost and coverage guide includes a full-cost calculation and a script you can use with a pharmacy or insurer.
Compare the whole cost
A useful quote separates the assessment, medication, dispensing, membership, follow-up and any tests that are actually required. Compare the first month with a typical later month. Confirm how much medication the quoted price covers.
If you are comparing two services, use the same product, quantity and time period. Keep clinical suitability separate from price: a lower quote for a different medicine is not a like-for-like comparison.
Your next step
Get the free GLP-1 appointment checklist to organize your care questions and compare two services. You can also browse BC providers or request navigation help if you need help finding a care pathway.
Frequently asked questions
Is Ozempic the same as Wegovy?
They share semaglutide as an ingredient, but they are different prescription products. Check the exact product's indication, presentation, prescription and coverage.
Is Mounjaro the same as Zepbound?
Both contain tirzepatide. Their Canadian product indications differ, and a prescription or benefit decision for one should not be assumed to apply to the other.
Can I get assessed online?
Some services offer virtual assessments. Check who provides care, what the consultation includes and how in-person examination or follow-up is arranged when needed. Paying for an assessment does not guarantee a prescription.
Are generic options automatically cheaper or covered?
Check the actual pharmacy quote and your plan. An approved generic product is not automatically stocked, substituted or paid for in every situation.
Can I compare providers before deciding about medication?
Yes. Start with the service's assessment and ongoing support. You do not need to decide on a medicine before learning what a consultation involves.
Choose the next useful step
| If you need to… | Start here |
|---|---|
| Prepare questions for an appointment | Open the GLP-1 planning toolkit and use the appointment checklist. |
| Check coverage or a pharmacy claim | Review the PharmaCare and insurance checklist, then ask about the exact product, indication and plan. |
| Compare total cost components | Read the B.C. GLP-1 cost guide and request like-for-like written information. |
| Verify a product record | Search the Health Canada Drug Product Database by product, ingredient or DIN. |
Free GLP-1 appointment checklist
Bring better questions to your first visit. This printable checklist includes a consultation planner, a two-service comparison and a cost checklist.
This guide provides general health information. A licensed clinician can help you decide what is appropriate for your circumstances. Sources were checked September 6, 2026.
Separate the three cost conversations
Answer first: an assessment fee, ongoing follow-up fee and medication/pharmacy cost can be separate charges. Ask for each in writing before choosing a service. Coverage for a diabetes indication does not establish coverage for weight management.
| Stage | What to confirm |
|---|---|
| Initial appointment | Who provides the assessment, what the appointment includes, whether any tests or documentation may be separately billed, and what happens if no prescription is issued. |
| Ongoing care | Follow-up cadence, membership or visit fees, the route for questions between appointments and the plan if treatment is changed or stopped. |
| Medication and pharmacy | The exact prescribed product and quantity, medication price, dispensing charge, stock availability, DIN where relevant, and whether the usual pharmacy can fill it. |
| Benefits | The exact product and indication, prior authorization, deductible, annual maximum, required paperwork and what written evidence the insurer needs before purchase. |
Prepare questions with the GLP-1 toolkit, review the BC PharmaCare and insurance checklist, compare total GLP-1 costs in B.C., and read the tirzepatide pharmacy and insurer questions. You can also use the weight-management care profiles to find publicly listed clinic contact details; profiles do not confirm prescribing, price or current availability.